Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | QGEN | RGEN | ||
| Company | Arrowhead Pharma | Qiagen N.V. | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 69.39 | 45.87 | 165.04 | ||
| High | 69.69 | 46.02 | 167.65 | ||
| Low | 68.00 | 45.44 | 161.41 | ||
| Latest | 69.62 | 45.60 | 165.73 | ||
| Change | -0.54 | +0.23 | -0.48 | ||
| % Change | -0.77% | +0.51% | -0.29% | ||
| Volume | 896,700 | 1,050,400 | 367,000 | ||
| 20-Day Average Volume | 2,817,365 | 1,197,900 | 619,275 | ||
| Previous Close | 70.16 | 45.37 | 166.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 66.69 | 45.86 | 162.91 | ||
| 20-Day Raw Stochastic | 86.39% | 30.11% | 64.80% | ||
| 20-Day Relative Strength | 68.84 | 47.98 | 57.24 | ||
| Weighted Alpha | +288.56 | -0.50 | +21.05 | ||
| Today's Opinion | 100% Buy | 32% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 48% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.14% since 12/19/25 | +0.04% since 12/19/25 | +2.06% since 12/19/25 | ||
| Low | 67.60 on 12/22/25 | 45.13 on 12/24/25 | 161.41 on 12/29/25 | ||
| High | 71.30 on 12/24/25 | 46.17 on 12/23/25 | 167.74 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +32.11% since 11/28/25 | -4.50% since 11/28/25 | -3.09% since 11/28/25 | ||
| Low | 52.23 on 12/01/25 | 44.51 on 12/16/25 | 156.01 on 12/16/25 | ||
| High | 72.36 on 12/11/25 | 48.13 on 12/01/25 | 171.01 on 12/01/25 | ||
| 3-Month | |||||
| %Chg | +106.10% since 09/29/25 | +3.78% since 09/29/25 | +33.56% since 09/29/25 | ||
| Low | 33.55 on 09/30/25 | 42.82 on 11/07/25 | 123.97 on 09/30/25 | ||
| High | 72.36 on 12/11/25 | 49.59 on 10/21/25 | 174.01 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | +332.96% since 06/27/25 | -4.54% since 06/27/25 | +34.13% since 06/27/25 | ||
| Low | 14.30 on 07/22/25 | 42.82 on 11/07/25 | 110.77 on 08/06/25 | ||
| High | 72.36 on 12/11/25 | 51.88 on 07/25/25 | 174.01 on 11/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,459,966 | 10,136,469 | 9,329,108 | ||
| Shares Outstanding, K | 135,880 | 222,291 | 56,291 | ||
| Annual Sales | 829,450,000 | 1,978,210,000 | 634,440,000 | ||
| Annual Net Income | -1,630,000 | 83,590,000 | -25,510,000 | ||
| Last Quarter Sales | 256,470,000 | 532,580,000 | 188,810,000 | ||
| Last Quarter Net Income | -23,750,000 | 130,040,000 | 14,910,000 | ||
| 60-Month Beta | 1.28 | 0.67 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/25/25 | 0.61 on 11/04/25 | 0.46 on 10/28/25 | ||
| Latest Earnings Date | 02/09/26 | 02/04/26 | 02/19/26 | ||
| Most Recent Dividend | N/A | 0.250 on 07/02/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/02/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.14 | 100.13 | ||